Xiangyang Chi

2.1k total citations
24 papers, 212 citations indexed

About

Xiangyang Chi is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Xiangyang Chi has authored 24 papers receiving a total of 212 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 9 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Xiangyang Chi's work include SARS-CoV-2 and COVID-19 Research (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Viral Infections and Outbreaks Research (5 papers). Xiangyang Chi is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Viral Infections and Outbreaks Research (5 papers). Xiangyang Chi collaborates with scholars based in China, Czechia and Poland. Xiangyang Chi's co-authors include Changming Yu, Ting Fang, Guanying Zhang, Shipo Wu, Xiaohong Song, Rui Yu, Zhengshan Chen, Jianmin Li, Lihua Hou and Wei Chen and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Frontiers in Immunology.

In The Last Decade

Xiangyang Chi

19 papers receiving 205 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangyang Chi China 9 116 67 53 49 29 24 212
Meghan Garrett United States 8 89 0.8× 75 1.1× 61 1.2× 62 1.3× 20 0.7× 19 234
Meiniang Wang China 7 200 1.7× 49 0.7× 39 0.7× 33 0.7× 17 0.6× 13 307
Premanand Balraj United States 11 99 0.9× 117 1.7× 56 1.1× 18 0.4× 86 3.0× 21 317
Jiahong Zhu China 8 35 0.3× 92 1.4× 24 0.5× 55 1.1× 18 0.6× 18 247
Lauren E. Gentles United States 6 156 1.3× 96 1.4× 56 1.1× 24 0.5× 10 0.3× 9 259
Leesa M. Kakutani United States 3 192 1.7× 94 1.4× 65 1.2× 47 1.0× 14 0.5× 5 257
Ainhoa Moliner Morro Sweden 7 261 2.3× 142 2.1× 47 0.9× 180 3.7× 10 0.3× 7 395
Andrena Millar United Kingdom 4 138 1.2× 77 1.1× 40 0.8× 108 2.2× 33 1.1× 6 308
Alan Yung-Chih Hu Taiwan 10 125 1.1× 115 1.7× 59 1.1× 26 0.5× 18 0.6× 21 323
Diana Edo-Matas Netherlands 11 160 1.4× 90 1.3× 74 1.4× 11 0.2× 48 1.7× 15 307

Countries citing papers authored by Xiangyang Chi

Since Specialization
Citations

This map shows the geographic impact of Xiangyang Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyang Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyang Chi more than expected).

Fields of papers citing papers by Xiangyang Chi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangyang Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyang Chi. The network helps show where Xiangyang Chi may publish in the future.

Co-authorship network of co-authors of Xiangyang Chi

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangyang Chi. A scholar is included among the top collaborators of Xiangyang Chi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangyang Chi. Xiangyang Chi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Yi, Pengfei Fan, Ting Fang, et al.. (2025). Potent Cross‐neutralizing Antibodies Reveal Vulnerabilities of Henipavirus Fusion Glycoprotein. Advanced Science. 12(27). e2501996–e2501996. 1 indexed citations
2.
Li, Jie, Shaoyan Wang, Yue Cui, et al.. (2025). Immunogenicity of differentially glycosylated Marburg virus glycoproteins expressed in mammalian and insect cells. Virology Journal. 22(1). 275–275.
3.
Zhang, Xinyi, Zhu Zhang, Peng Zhai, et al.. (2025). Protection against lethal HAdV-4 challenge in STAT1 mice by novel human monoclonal antibodies. Frontiers in Immunology. 16. 1613945–1613945.
4.
Zhang, Guanying, Ping Huang, Hongyu Yuan, et al.. (2025). Nasal delivery of secretory IgA confers enhanced neutralizing activity against Omicron variants compared to its IgG counterpart. Molecular Therapy. 33(4). 1687–1700. 1 indexed citations
5.
Lv, Peng, Sen Zhang, Zheng Zhu, et al.. (2025). Licoflavone B Suppresses Influenza A Virus by Targeting the Viral RNA-Dependent RNA Polymerase (RdRp). Viruses. 17(9). 1157–1157.
6.
7.
Zhang, Yuanyuan, Guanying Zhang, Ping Huang, et al.. (2024). A novel bispecific antibody targeting two overlapping epitopes in RBD improves neutralizing potency and breadth against SARS-CoV-2. Emerging Microbes & Infections. 13(1). 2373307–2373307. 3 indexed citations
8.
Chi, Xiangyang, Guanying Zhang, Ximin Chi, et al.. (2023). Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variants. Cell Discovery. 9(1). 37–37. 6 indexed citations
9.
Zeng, Weihong, Xiaoying Jia, Xiangyang Chi, et al.. (2023). An engineered bispecific nanobody in tetrameric secretory IgA format confers broad neutralization against SARS-CoV-1&2 and most variants. International Journal of Biological Macromolecules. 253(Pt 3). 126817–126817. 7 indexed citations
10.
11.
Wang, Meirong, Ruihua Li, Yaohui Li, et al.. (2021). Construction and Immunological Evaluation of an Adenoviral Vector-Based Vaccine Candidate for Lassa Fever. Viruses. 13(3). 484–484. 8 indexed citations
12.
Cao, Qiqi, Shipo Wu, Chuan‐Le Xiao, et al.. (2021). Integrated single-cell analysis revealed immune dynamics during Ad5-nCoV immunization. Cell Discovery. 7(1). 64–64. 22 indexed citations
13.
Fan, Pengfei, Xiangyang Chi, Guodong Liu, et al.. (2020). Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors. mAbs. 12(1). 1742457–1742457. 17 indexed citations
14.
Zhang, Guanying, Rui Yu, Xiangyang Chi, et al.. (2020). Tetanus vaccine-induced human neutralizing antibodies provide full protection against neurotoxin challenge in mice. International Immunopharmacology. 91. 107297–107297. 6 indexed citations
15.
Hao, Meng, Guanying Zhang, Zhengshan Chen, et al.. (2020). Characterization of Two Neutralizing Antibodies against Rift Valley Fever Virus Gn Protein. Viruses. 12(3). 259–259. 12 indexed citations
16.
Ren, Jun, Jinlong Zhang, Xiaohong Song, et al.. (2017). Identification and characterization of a neutralizing monoclonal antibody that provides complete protection against Yersinia pestis. PLoS ONE. 12(5). e0177012–e0177012. 8 indexed citations
17.
Liu, Ju, Ruihua Li, Kun Liu, et al.. (2016). Identification of antigen-specific human monoclonal antibodies using high-throughput sequencing of the antibody repertoire. Biochemical and Biophysical Research Communications. 473(1). 23–28. 3 indexed citations
18.
Chi, Xiangyang, Jianmin Li, Xiaolin Wang, et al.. (2015). Generation and Characterization of Human Monoclonal Antibodies Targeting Anthrax Protective Antigen following Vaccination with a Recombinant Protective Antigen Vaccine. Clinical and Vaccine Immunology. 22(5). 553–560. 10 indexed citations
19.
Liu, Ying, Zhe Zhang, Xinghui Zhao, et al.. (2014). Enterovirus 71 Inhibits Cellular Type I Interferon Signaling by Downregulating JAK1 Protein Expression. Viral Immunology. 27(6). 267–276. 35 indexed citations
20.
Chi, Xiangyang, Yvonne Landt, Dan L. Crimmins, Brian K. Dieckgraefe, & Jack H. Ladenson. (2002). Isolation and characterization of rabbit single chain antibodies to human Reg Iα protein. Journal of Immunological Methods. 266(1-2). 197–207. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meghan Garrett Breakdown of academic impact, for papers by Meiniang Wang Breakdown of academic impact, for papers by Premanand Balraj Breakdown of academic impact, for papers by Jiahong Zhu Breakdown of academic impact, for papers by Lauren E. Gentles Breakdown of academic impact, for papers by Leesa M. Kakutani Breakdown of academic impact, for papers by Ainhoa Moliner Morro Breakdown of academic impact, for papers by Andrena Millar Breakdown of academic impact, for papers by Alan Yung-Chih Hu Breakdown of academic impact, for papers by Diana Edo-Matas
Rankless by CCL
2026